254 related articles for article (PubMed ID: 25073644)
1. Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens.
Czyż DM; Potluri LP; Jain-Gupta N; Riley SP; Martinez JJ; Steck TL; Crosson S; Shuman HA; Gabay JE
mBio; 2014 Jul; 5(4):e01534-14. PubMed ID: 25073644
[TBL] [Abstract][Full Text] [Related]
2. Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells.
Fullerton MS; Colonne PM; Dragan AL; Brann KR; Kurten RC; Voth DE
mSphere; 2021 Aug; 6(4):e0044221. PubMed ID: 34232075
[TBL] [Abstract][Full Text] [Related]
3. Elevated Cholesterol in the
Mulye M; Samanta D; Winfree S; Heinzen RA; Gilk SD
mBio; 2017 Feb; 8(1):. PubMed ID: 28246364
[No Abstract] [Full Text] [Related]
4. Type IVB secretion by intracellular pathogens.
Sexton JA; Vogel JP
Traffic; 2002 Mar; 3(3):178-85. PubMed ID: 11886588
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of pathogen-induced apoptosis by a Coxiella burnetii type IV effector protein.
Lührmann A; Nogueira CV; Carey KL; Roy CR
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18997-9001. PubMed ID: 20944063
[TBL] [Abstract][Full Text] [Related]
6. Functional similarities between the icm/dot pathogenesis systems of Coxiella burnetii and Legionella pneumophila.
Zusman T; Yerushalmi G; Segal G
Infect Immun; 2003 Jul; 71(7):3714-23. PubMed ID: 12819052
[TBL] [Abstract][Full Text] [Related]
7. Dependency of
Larson CL; Beare PA; Heinzen RA
J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31501284
[TBL] [Abstract][Full Text] [Related]
8. Legionella and Coxiella effectors: strength in diversity and activity.
Qiu J; Luo ZQ
Nat Rev Microbiol; 2017 Oct; 15(10):591-605. PubMed ID: 28713154
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis.
Rolain JM; Maurin M; Bryskier A; Raoult D
Antimicrob Agents Chemother; 2000 May; 44(5):1391-3. PubMed ID: 10770788
[TBL] [Abstract][Full Text] [Related]
10. Exploring anti-bacterial compounds against intracellular Legionella.
Harrison CF; Kicka S; Trofimov V; Berschl K; Ouertatani-Sakouhi H; Ackermann N; Hedberg C; Cosson P; Soldati T; Hilbi H
PLoS One; 2013; 8(9):e74813. PubMed ID: 24058631
[TBL] [Abstract][Full Text] [Related]
11. Brucella abortus Induces a Warburg Shift in Host Metabolism That Is Linked to Enhanced Intracellular Survival of the Pathogen.
Czyż DM; Willett JW; Crosson S
J Bacteriol; 2017 Aug; 199(15):. PubMed ID: 28559292
[TBL] [Abstract][Full Text] [Related]
12. Speculations on the influence of infecting phenotype on virulence and antibiotic susceptibility of Legionella pneumophila.
Barker J; Brown MR
J Antimicrob Chemother; 1995 Jul; 36(1):7-21. PubMed ID: 8537286
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila.
Takemura H; Yamamoto H; Kunishima H; Ikejima H; Hara T; Kanemitsu K; Terakubo S; Shoji Y; Kaku M; Shimada J
J Antimicrob Chemother; 2000 Oct; 46(4):589-94. PubMed ID: 11020257
[TBL] [Abstract][Full Text] [Related]
14. KKL-35 Exhibits Potent Antibiotic Activity against Legionella Species Independently of
Brunel R; Descours G; Durieux I; Doublet P; Jarraud S; Charpentier X
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158279
[No Abstract] [Full Text] [Related]
15. Evolution and function of bacterial RCC1 repeat effectors.
Swart AL; Gomez-Valero L; Buchrieser C; Hilbi H
Cell Microbiol; 2020 Oct; 22(10):e13246. PubMed ID: 32720355
[TBL] [Abstract][Full Text] [Related]
16. Large-scale identification and translocation of type IV secretion substrates by Coxiella burnetii.
Chen C; Banga S; Mertens K; Weber MM; Gorbaslieva I; Tan Y; Luo ZQ; Samuel JE
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21755-60. PubMed ID: 21098666
[TBL] [Abstract][Full Text] [Related]
17. A dual-targeting approach to inhibit Brucella abortus replication in human cells.
Czyż DM; Jain-Gupta N; Shuman HA; Crosson S
Sci Rep; 2016 Oct; 6():35835. PubMed ID: 27767061
[TBL] [Abstract][Full Text] [Related]
18. An in vivo high-throughput screening approach targeting the type IV secretion system component VirB8 identified inhibitors of Brucella abortus 2308 proliferation.
Paschos A; den Hartigh A; Smith MA; Atluri VL; Sivanesan D; Tsolis RM; Baron C
Infect Immun; 2011 Mar; 79(3):1033-43. PubMed ID: 21173315
[TBL] [Abstract][Full Text] [Related]
19. The role of Rab GTPases in the transport of vacuoles containing Legionella pneumophila and Coxiella burnetii.
Hardiman CA; McDonough JA; Newton HJ; Roy CR
Biochem Soc Trans; 2012 Dec; 40(6):1353-9. PubMed ID: 23176480
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput Intracellular Antimicrobial Susceptibility Testing of Legionella pneumophila.
Chiaraviglio L; Kirby JE
Antimicrob Agents Chemother; 2015 Dec; 59(12):7517-29. PubMed ID: 26392509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
